259 related articles for article (PubMed ID: 24323790)
1. Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines.
Nakowitsch S; Waltenberger AM; Wressnigg N; Ferstl N; Triendl A; Kiefmann B; Montomoli E; Lapini G; Sergeeva M; Muster T; Romanova JR
Biotechnol J; 2014 Mar; 9(3):405-14. PubMed ID: 24323790
[TBL] [Abstract][Full Text] [Related]
2. Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1.
Nakowitsch S; Wolschek M; Morokutti A; Ruthsatz T; Krenn BM; Ferko B; Ferstl N; Triendl A; Muster T; Egorov A; Romanova J
Vaccine; 2011 Apr; 29(19):3517-24. PubMed ID: 21406268
[TBL] [Abstract][Full Text] [Related]
3. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
[TBL] [Abstract][Full Text] [Related]
4. Rapid generation of a well-matched vaccine seed from a modern influenza A virus primary isolate without recourse to eggs.
Hartgroves LC; Koudstaal W; McLeod C; Moncorgé O; Thompson CI; Ellis J; Bull C; Havenga MJ; Goudsmit J; Barclay WS
Vaccine; 2010 Apr; 28(17):2973-9. PubMed ID: 20188682
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
[TBL] [Abstract][Full Text] [Related]
6. [Rescue of H3N2 subtype swine influenza virus and substitution of hemagglutinin, neuraminidase].
Du J; Liu M; Liu C; Yang T; Li H
Wei Sheng Wu Xue Bao; 2009 Jun; 49(6):813-9. PubMed ID: 19673419
[TBL] [Abstract][Full Text] [Related]
7. A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.
Wen F; Li L; Zhao N; Chiang MJ; Xie H; Cooley J; Webby R; Wang PG; Wan XF
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118117
[TBL] [Abstract][Full Text] [Related]
8. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
9. Stability of neuraminidase in inactivated influenza vaccines.
Sultana I; Yang K; Getie-Kebtie M; Couzens L; Markoff L; Alterman M; Eichelberger MC
Vaccine; 2014 Apr; 32(19):2225-30. PubMed ID: 24613525
[TBL] [Abstract][Full Text] [Related]
10. [Characterization of influenza virus reassortants based on new donor strain A/HK/1/68/162/35(H3N2)].
Potapchuk MV; Repko IA; Sergeeva MV; Korotkov AV; Komissarov AB; Sandybaev NT; Cherviakova OV; Khaĭrullin VM; Tsybalova LM
Vopr Virusol; 2012; 57(6):42-6. PubMed ID: 23477254
[TBL] [Abstract][Full Text] [Related]
11. Antigenic and genetic variation in the hemagglutinins of H1N1 and H3N2 human influenza a viruses in the Shanghai area from 2005 to 2008.
Ren XW; Ju LW; Yang JX; Lv XH; Jiang LF; Zhao NQ; Jiang QW
J Med Virol; 2011 Jul; 83(7):1113-20. PubMed ID: 21520138
[TBL] [Abstract][Full Text] [Related]
12. Toward animal cell culture-based influenza vaccine design: viral hemagglutinin N-glycosylation markedly impacts immunogenicity.
Hütter J; Rödig JV; Höper D; Seeberger PH; Reichl U; Rapp E; Lepenies B
J Immunol; 2013 Jan; 190(1):220-30. PubMed ID: 23225881
[TBL] [Abstract][Full Text] [Related]
13. The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response.
Chen Z; Zhou H; Jin H
Vaccine; 2010 May; 28(24):4079-85. PubMed ID: 20399830
[TBL] [Abstract][Full Text] [Related]
14. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics.
Lu B; Zhou H; Ye D; Kemble G; Jin H
J Virol; 2005 Jun; 79(11):6763-71. PubMed ID: 15890915
[TBL] [Abstract][Full Text] [Related]
15. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
[TBL] [Abstract][Full Text] [Related]
16. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
17. Genetic engineering of live attenuated influenza viruses.
Jin H; Chen Z; Liu J; Kemble G
Methods Mol Biol; 2012; 865():163-74. PubMed ID: 22528159
[TBL] [Abstract][Full Text] [Related]
18. In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains.
Galli C; Orsi A; Pariani E; Lai PL; Guarona G; Pellegrinelli L; Ebranati E; Icardi G; Panatto D
Expert Rev Vaccines; 2020 Jan; 19(1):115-122. PubMed ID: 31875483
[No Abstract] [Full Text] [Related]
19. Vaccine-induced protection from egg production losses in commercial turkey breeder hens following experimental challenge with a triple-reassortant H3N2 avian influenza virus.
Kapczynski DR; Gonder E; Liljebjelke K; Lippert R; Petkov D; Tilley B
Avian Dis; 2009 Mar; 53(1):7-15. PubMed ID: 19431997
[TBL] [Abstract][Full Text] [Related]
20. The stability and immunogenicity of inactivated MDCK cell-derived influenza H7N9 viruses.
Tzeng TT; Lai CC; Weng TC; Cyue MH; Tsai SY; Tseng YF; Sung WC; Lee MS; Hu AY
Vaccine; 2019 Nov; 37(47):7117-7122. PubMed ID: 31383484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
